“Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 and 2 and ADOL)” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s48. doi:10.25251/skin.4.supp.47.